Skip to main content
Top

Journal of Endocrinological Investigation

Issue 3/2020

Content (17 Articles)

Obituary

Obituary: Renato Pasquali (1946–2019)

A. Gambineri, G. Di Dalmazi, F. Fanelli, P. Altieri, A. Repaci, S. Garelli, D. Ribichini, C. Pelusi, V. Vicennati, U. Pagotto

Thyroid autoimmunity and risk of post-partum depression: a systematic review and meta-analysis of longitudinal studies

E. Minaldi, S. D’Andrea, C. Castellini, A. Martorella, F. Francavilla, S. Francavilla, A. Barbonetti

Acromegaly and ultrasound: how, when and why?

M. Parolin, F. Dassie, R. Vettor, P. Maffei

Dapagliflozin Original Article

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis

E. G. Dorsey-Treviño, J. G. González-González, N. Alvarez-Villalobos, V. González-Nava, B. M. Contreras-Garza, A. Díaz González-Colmenero, G. Rodríguez-Tamez, F. J. Barrera-Flores, A. M. Farrell, V. M. Montori, R. Rodriguez-Gutierrez

Dapagliflozin Original Article

Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study

G. P. Fadini, P. Li Volsi, E. Devangelio, M. Poli, G. Cazzetta, G. Felace, A. Avogaro, Agostino Consoli, Gloria Formoso, Giovanni Grossi, Achiropita Pucci, Giorgio Sesti, Francesco Andreozzi, Giuseppe Capobianco, Adriano Gatti, Riccardo Bonadonna, Ivana Zavaroni, Alessandra Dei Cas, Giuseppe Felace, Patrizia Li Volsi, Raffaella Buzzetti, Gaetano Leto, Gian Pio Sorice, Paola D’Angelo, Susanna Morano, Antonio Carlo Bossi, Edoardo Duratorre, Ivano Franzetti, Paola Silvia Morpurgo, Emanuela Orsi, Fabrizio Querci, Massimo Boemi, Federica D’Angelo, Massimiliano Petrelli, Gianluca Aimaretti, Ioannis Karamouzis, Franco Cavalot, Giuseppe Saglietti, Giuliana Cazzetta, Silvestre Cervone, Eleonora Devangelio, Olga Lamacchia, Salvatore Arena, Antonino Di Benedetto, Lucia Frittitta, Carla Giordano, Salvatore Piro, Manfredi Rizzo, Roberta Chianetta, Carlo Mannina, Roberto Anichini, Giuseppe Penno, Anna Solini, Bruno Fattor, Enzo Bonora, Massimo Cigolini, Annunziata Lapolla, Nino Cristiano Chilelli, Maurizio Poli, Natalino Simioni, Vera Frison, Carmela Vinci

Levothyroxine Original Article

Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study

E. M. Presotto, G. Rastrelli, I. Desideri, V. Scotti, S. Gunnella, N. Pimpinelli, E. Vaccher, A. Bearz, F. Di Costanzo, M. Bruggia, E. Mini, M. Maggi, A. Peri

Hyperparathyroidism Original Article

Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy

M. Liu, M. Sum, E. Cong, I. Colon, M. Bucovsky, J. Williams, A. Kepley, J. Kuo, J. A. Lee, R. M. Lazar, R. Marshall, S. Silverberg, M. D. Walker

Septicemia Brief Report

Oral steroid prophylaxis for Graves’ orbitopathy after radioactive iodine treatment for Graves’ disease is not only effective, but also safe

S. Rosetti, M. L. Tanda, G. Veronesi, E. Masiello, P. Premoli, D. Gallo, C. Cusini, S. Donati, J. Sabatino, S. Ippolito, E. Piantanida, L. Bartalena

Happy 20th birthday to minimally invasive video-assisted thyroidectomy!

G. Dionigi, H. Dralle, G. Materazzi, H. Y. Kim, P. Miccoli

Metformin Comment

Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients

Claudia Teti, Miryam Talco, Manuela Albertelli, Valeria Albanese, Michele Minuto, Alberto Aglialoro, Mario Monachesi, Giorgio Viviani, Federico Gatto, Diego Ferone, Mara Boschetti

Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism

F. Cetani, E. Pardi, P. Aretini, F. Saponaro, S. Borsari, L. Mazoni, M. Apicella, P. Civita, M. La Ferla, M. A. Caligo, F. Lessi, C. M. Mazzanti, L. Torregrossa, A. Oppo, C. Marcocci

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine